About Plusgen India Private Limited
Data last updated: 17 February 2026
Plusgen India Private Limited is a private limited company based in Gurugram, Haryana, India, recognised as a startup by DPIIT. It specialises in business support services, a part of the broader business services sector. Incorporated on 26 October 2022.
Registered with ROC Haryana under CIN U74999HR2022PTC107380.
Capital: an authorised share capital of ₹15 Lakh and a paid-up capital of ₹15 Lakh. It is led by directors Ashwani Kumar Bhatia and Anil Kumar.
Last AGM: 30 September 2025. Financial statements filed for year ended 31 March 2025. Office: Plot No. 581 Sector – 37 Pace City – 2, Gurugram, Haryana, India – 122004.
As per the financials filed for FY 2024, the company reported a revenue of ₹2.49 Cr.
The company is associated with 1 brand - Plusgen India. As per MCA filings, the company has open charges of ₹4.3 Cr on record.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website plusgenindia.com.
-
Email*****@*****.com
-
Telephone+91-****-******
-
Website
-
Social Media**************
-
Registered AddressPlot No. 581 Sector – 37 Pace City – 2, Gurugram, Haryana, India – 122004
-
IndustryBusiness Services, Business Support Services
- Historical Financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Litigation, compliance and MCA filings
- PDF report delivered after checkout
Associated Brands with Plusgen India Private Limited
Plusgen India Private Limited operates one associated brand: PlusGen India. These brands represent Plusgen India Private Limited's diversified market presence and brand portfolio.
| Brand | Description | Website |
|---|---|---|
| Distributes pharmaceuticals including antibiotics and cardiovascular drugs to retailers and institutions. | plusgenindia.com |
Competitors & Alternatives of Plusgen India Private Limited
Brands and companies operating in the same space as Plusgen India Private Limited include Pfizer, Entero Healthcare, AmerisourceBergen and 7 more.
| Competitor | Description | Location | Founded |
|---|---|---|---|
Pfizer
|
Pharmaceutical products for treating multiple diseases are provided. | New York, United States, United States | 1849 |
Entero Healthcare
|
India's leading healthcare products distribution platform | Mumbai, India, India | 2018 |
AmerisourceBergen
|
Pharmaceutical distribution and supply chain services are provided globally. | Chesterbrook, United States, United States | 1985 |
Keimed
|
Temperature-sensitive medicines are distributed via cold chain logistics by Keimed. | Hyderabad, India, India | 2000 |
EBOS Group
|
Wholesaler & distributor of healthcare, medical, and pharmaceutical products | Docklands, Australia, Australia | 1922 |
Target Healthcare
|
Distributor of pharmaceutical products | East Kilbride, United Kingdom, United Kingdom | 2012 |
CHEPLAPHARM
|
Branded pharmaceutical products are developed, marketed, and distributed globally. | Mesekenhagen, Germany, Germany | 1998 |
NEUCA
|
Wholesale distribution of pharmaceuticals is managed by NEUCA in Poland. | Torun, Poland, Poland | 1990 |
Oriola
|
Pharmaceutical drugs and supplements are distributed by Oriola in Finland. | Espoo, Finland, Finland | 1997 |
Renee
|
Diversified drugs are distributed by Renee in the United States. | Los Angeles, United States, United States | 2021 |
Business Activity of Plusgen India Private Limited
Plusgen India Private Limited is engaged in the principal business activity of trade, with detailed activities including wholesale trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | ********* |
Auditor Details of Plusgen India Private Limited
Plusgen India Private Limited is audited by Himanshu Khurana and Co. for the financial year 2023. The auditor plays a crucial role in ensuring financial transparency and compliance with accounting standards.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| Himanshu Khurana and Co. | blur-value | blur-value | blur-value |
Board of Directors of Plusgen India Private Limited
Plusgen India Private Limited is governed by 2 directors who oversee the company's operations and strategic decisions.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
|
Ashwani Kumar Bhatia
Also directs:
Scarlet Formulation Private Limited, Ruchi Pharma Distributors Private Limited, Medcart Anteka Private Limited and 5 more
|
Director | 26 Oct 2022 | 3 Years 8 Months | Current |
|
Anil Kumar
Also directs:
Almo Impex (India) Private Limited, Almo Exports Private Limited, Scarlet Formulation Private Limited and 5 more
|
Director | 26 Oct 2022 | 3 Years 8 Months | Current |
Financials of Plusgen India Private Limited FY 2025 filings available
Plusgen India Private Limited reported revenue of ₹2.49 Cr (up ) for FY 2024. Profit growth despite declining revenue indicates effective cost management and margin discipline.
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue from Operations | ***** | ***** | ***** | ***** | ***** |
| Revenue Growth % | ***** | ***** | ***** | ***** | ***** |
| Other Income | ***** | ***** | ***** | ***** | ***** |
| Total Revenue | ***** | ***** | ***** | ***** | ***** |
| Expenses | |||||
| Total Expenses | ***** | ***** | ***** | ***** | ***** |
| Raw Material Cost | ***** | ***** | ***** | ***** | ***** |
| Change in Inventory FG | ***** | ***** | ***** | ***** | ***** |
| Change in Inventory WIP | ***** | ***** | ***** | ***** | ***** |
| Purchase of Traded Goods | ***** | ***** | ***** | ***** | ***** |
| Employee Cost | ***** | ***** | ***** | ***** | ***** |
| Managerial Remuneration | ***** | ***** | ***** | ***** | ***** |
| Audit Fees | ***** | ***** | ***** | ***** | ***** |
| Insurance | ***** | ***** | ***** | ***** | ***** |
| Power & Fuel | ***** | ***** | ***** | ***** | ***** |
| Interest | ***** | ***** | ***** | ***** | ***** |
| Depreciation | ***** | ***** | ***** | ***** | ***** |
| Other Expenses | ***** | ***** | ***** | ***** | ***** |
| Profitability | |||||
| EBITDA (Operating Profit) | ***** | ***** | ***** | ***** | ***** |
| Operating Margin % | ***** | ***** | ***** | ***** | ***** |
| Exceptional Items | ***** | ***** | ***** | ***** | ***** |
| Extraordinary Items | ***** | ***** | ***** | ***** | ***** |
| Profit Before Exceptional & Extraordinary Items | ***** | ***** | ***** | ***** | ***** |
| Profit Before Tax | ***** | ***** | ***** | ***** | ***** |
| Tax & Net Profit | |||||
| Tax Expense | ***** | ***** | ***** | ***** | ***** |
| Current Tax | ***** | ***** | ***** | ***** | ***** |
| Deferred Tax | ***** | ***** | ***** | ***** | ***** |
| Profit from Discontinued Operations | ***** | ***** | ***** | ***** | ***** |
| Tax on Discontinued Operations | ***** | ***** | ***** | ***** | ***** |
| Profit | ***** | ***** | ***** | ***** | ***** |
| Net Margin % | ***** | ***** | ***** | ***** | ***** |
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Shareholders' Funds | |||||
| Total Shareholders' Funds | ***** | ***** | ***** | ***** | ***** |
| Equity Capital | ***** | ***** | ***** | ***** | ***** |
| Reserves & Surplus | ***** | ***** | ***** | ***** | ***** |
| Money Against Warrants | ***** | ***** | ***** | ***** | ***** |
| Other Equity | ***** | ***** | ***** | ***** | ***** |
| Non-Current Liabilities | |||||
| Total Non-Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Long-Term Borrowings | ***** | ***** | ***** | ***** | ***** |
| Deferred Tax Liabilities | ***** | ***** | ***** | ***** | ***** |
| Other Non-Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Long-Term Provisions | ***** | ***** | ***** | ***** | ***** |
| Current Liabilities | |||||
| Total Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Short-Term Borrowings | ***** | ***** | ***** | ***** | ***** |
| Trade Payables | ***** | ***** | ***** | ***** | ***** |
| Other Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Short-Term Provisions | ***** | ***** | ***** | ***** | ***** |
| Total Equity & Liabilities | ***** | ***** | ***** | ***** | ***** |
| Non-Current Assets | |||||
| Non-Current Assets | ***** | ***** | ***** | ***** | ***** |
| Tangible Assets | ***** | ***** | ***** | ***** | ***** |
| Intangible Assets | ***** | ***** | ***** | ***** | ***** |
| Capital WIP | ***** | ***** | ***** | ***** | ***** |
| Intangibles Under Dev | ***** | ***** | ***** | ***** | ***** |
| Investments | ***** | ***** | ***** | ***** | ***** |
| Deferred Tax Assets | ***** | ***** | ***** | ***** | ***** |
| LT Loans & Advances | ***** | ***** | ***** | ***** | ***** |
| Other Non-Current Assets | ***** | ***** | ***** | ***** | ***** |
| Current Assets | |||||
| Current Assets | ***** | ***** | ***** | ***** | ***** |
| Current Investments | ***** | ***** | ***** | ***** | ***** |
| Inventories | ***** | ***** | ***** | ***** | ***** |
| Trade Receivables | ***** | ***** | ***** | ***** | ***** |
| Cash & Bank Balance | ***** | ***** | ***** | ***** | ***** |
| ST Loans & Advances | ***** | ***** | ***** | ***** | ***** |
| Other Current Assets | ***** | ***** | ***** | ***** | ***** |
| Total Assets | ***** | ***** | ***** | ***** | ***** |
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Cash from Operating Activities (CFO) | |||||
| Profit Before Tax | ***** | ***** | ***** | ***** | ***** |
| Non-Cash Adjustments | ***** | ***** | ***** | ***** | ***** |
| + Interest Expense | ***** | ***** | ***** | ***** | ***** |
| + Depreciation | ***** | ***** | ***** | ***** | ***** |
| +/- Unrealized Forex | ***** | ***** | ***** | ***** | ***** |
| - Dividend Income | ***** | ***** | ***** | ***** | ***** |
| - Interest Income | ***** | ***** | ***** | ***** | ***** |
| +/- Other Non-Cash Items | ***** | ***** | ***** | ***** | ***** |
| Changes in Working Capital | ***** | ***** | ***** | ***** | ***** |
| +/- Inventory | ***** | ***** | ***** | ***** | ***** |
| +/- Debtors | ***** | ***** | ***** | ***** | ***** |
| +/- Creditors | ***** | ***** | ***** | ***** | ***** |
| Reconciliation Adjustments | ***** | ***** | ***** | ***** | ***** |
| Cash Generated from Operations | ***** | ***** | ***** | ***** | ***** |
| Income Taxes Paid | ***** | ***** | ***** | ***** | ***** |
| Net CFO (Cash from Operations) | ***** | ***** | ***** | ***** | ***** |
| Cash from Investing Activities (CFI) | |||||
| Acquisitions & Disposals | ***** | ***** | ***** | ***** | ***** |
| Disposal of Subsidiaries | ***** | ***** | ***** | ***** | ***** |
| Acquisition of Subsidiaries | ***** | ***** | ***** | ***** | ***** |
| Capex | ***** | ***** | ***** | ***** | ***** |
| Purchase of Fixed Assets | ***** | ***** | ***** | ***** | ***** |
| Sale of Fixed Assets | ***** | ***** | ***** | ***** | ***** |
| Other Investing Cash Flows | ***** | ***** | ***** | ***** | ***** |
| Net CFI (Cash from Investing) | ***** | ***** | ***** | ***** | ***** |
| Cash from Financing Activities (CFF) | |||||
| Equity Issuance | ***** | ***** | ***** | ***** | ***** |
| Debt Raised | ***** | ***** | ***** | ***** | ***** |
| Debt Repaid | ***** | ***** | ***** | ***** | ***** |
| Dividends Paid | ***** | ***** | ***** | ***** | ***** |
| Interest Paid | ***** | ***** | ***** | ***** | ***** |
| Net CFF (Cash from Financing) | ***** | ***** | ***** | ***** | ***** |
| Net Cash Position | |||||
| Net Change in Cash (Pre-Forex) | ***** | ***** | ***** | ***** | ***** |
| Closing Cash & Equivalents | ***** | ***** | ***** | ***** | ***** |
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Liquidity | |||||
| Current Ratio | ***** | ***** | ***** | ***** | ***** |
| Quick Ratio | ***** | ***** | ***** | ***** | ***** |
| Cash Ratio | ***** | ***** | ***** | ***** | ***** |
| Efficiency | |||||
| Inventory Days | ***** | ***** | ***** | ***** | ***** |
| Debtor Days | ***** | ***** | ***** | ***** | ***** |
| Creditor Days | ***** | ***** | ***** | ***** | ***** |
| Cash Conversion Cycle | ***** | ***** | ***** | ***** | ***** |
| Asset Turnover | ***** | ***** | ***** | ***** | ***** |
| Profitability | |||||
| Net Profit Margin % | ***** | ***** | ***** | ***** | ***** |
| Operating Margin % | ***** | ***** | ***** | ***** | ***** |
| ROE % | ***** | ***** | ***** | ***** | ***** |
| ROCE % | ***** | ***** | ***** | ***** | ***** |
| Net Worth Margin % | ***** | ***** | ***** | ***** | ***** |
| Growth | |||||
| Revenue Growth % | ***** | ***** | ***** | ***** | ***** |
| Leverage | |||||
| Equity Multiplier | ***** | ***** | ***** | ***** | ***** |
| Debt / EBITDA | ***** | ***** | ***** | ***** | ***** |
| Solvency | |||||
| D/E Ratio | ***** | ***** | ***** | ***** | ***** |
| ICR | ***** | ***** | ***** | ***** | ***** |
Consolidated Statements
Income Statement, Balance Sheet, Cash Flow & Ratios available in the full report.
Shareholding Pattern of Plusgen India Private Limited
As of FY 2023, Plusgen India Private Limited's shareholding pattern shows 100.00% by promoters. The promoters hold a majority stake, indicating strong promoter control.
| Year | 2025 |
|---|---|
| Promoters | 33.19% |
| DII | 23.22% |
| FII | 18.28% |
| Public | 22.89% |
| Others | 2.42% |
Charges & Borrowings of Plusgen India Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 20 Mar 2024 | Others | ₹4.3 Cr | Open |
Total charge records: 1 View all charges
Employees and EPFO Compliance at Plusgen India Private Limited
Plusgen India Private Limited has a workforce of 0 employees as of Apr 04, 2024.
Employee Count & EPFO Data of Plusgen India Private Limited
Access employee headcount trends, monthly PF payment records, EPFO establishment details, and compliance data.
GST Compliance of Plusgen India Private Limited
GSTIN & GST Filing Data of Plusgen India Private Limited
Access GSTIN registrations, state-wise filing compliance, HSN/SAC codes, and detailed goods & services data.
Credit Ratings, Litigation & Regulatory Alerts for Plusgen India Private Limited
Credit Ratings, Legal Cases & Regulatory Alerts of Plusgen India Private Limited
Access complete credit rating history, litigation records, regulatory alerts, and compliance data.
MSME Payment Delays by Plusgen India Private Limited
MSME Payment Delays by Plusgen India Private Limited
Track payments outstanding to micro and small enterprise vendors, as disclosed in half-yearly MSME-1 returns filed with the MCA.
Subsidiaries & Group Companies of Plusgen India Private Limited
Subsidiaries & Group Companies of Plusgen India Private Limited
See the full corporate group - holding company, subsidiaries, associates and joint ventures of Plusgen India Private Limited with ownership details.
MCA Filings & Documents of Plusgen India Private Limited
MCA Filings & Documents of Plusgen India Private Limited
Download official documents filed with the Ministry of Corporate Affairs - from incorporation papers to the latest annual filings.
Recent Activity on Plusgen India Private Limited
Frequently Asked Questions about Plusgen India Private Limited
Plusgen India Private Limited is an active private limited company in the business services sector based in Gurugram, Haryana, India. It was incorporated on 26 October 2022 (4+ years old) and is registered under CIN U74999HR2022PTC107380.
Plusgen India Private Limited reported revenue of ₹2.49 Cr for FY 2024.
The current directors of Plusgen India Private Limited are:
The primary industry of Plusgen India Private Limited is business services. The company specifically operates in business support services. The company is currently active in this sector.
Yes, Plusgen India Private Limited is recognised as a startup by the Department for Promotion of Industry and Internal Trade (DPIIT).
Plusgen India Private Limited can be reached at the registered office: Plot No. 581 Sector – 37 Pace City – 2, Gurugram, Haryana, India – 122004, or through the website plusgenindia.com.